| Recruiting | Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies NCT06664528 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINST NCT05465031 | Silesian Centre for Heart Diseases | Phase 4 |
| Recruiting | The STOP-MED CTRCD Trial NCT06183437 | Dinesh Thavendiranathan | Phase 4 |
| Completed | Translating ECHOS2 Into an mHealth Platform NCT05923242 | Washington University School of Medicine | N/A |
| Unknown | Cardiovascular Effects of Intrathecal Hyperbaric Prilocaine or Bupivacaine in Surgery Under Spinal Anesthesia NCT05751148 | Centre Hospitalier Universitaire Saint Pierre | N/A |
| Recruiting | Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted NCT05559164 | Rutgers, The State University of New Jersey | Phase 2 |
| Unknown | Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude NCT05063643 | Affiliated Hospital of Qinghai University | — |
| Active Not Recruiting | Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatme NCT06277388 | Sun Yat-sen University | — |
| Unknown | Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy NCT04867564 | Military Institute od Medicine National Research Institute | — |
| Unknown | Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients NCT04962425 | Peking University Third Hospital | — |
| Unknown | Exercise Response After Revalidation in Cancer Patients NCT04461392 | Universitair Ziekenhuis Brussel | N/A |
| Unknown | Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial Function NCT04962438 | Peking University Third Hospital | — |
| Completed | Association Between Telomere Length and Cardiac Dysfunction NCT04409379 | Air Force Military Medical University, China | — |
| Completed | The CAROLE (CArdiac Related Oncologic Late Effects) Study NCT03235427 | Northwell Health | — |
| Completed | BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study NCT02605512 | Sophie JACOB | N/A |
| Recruiting | COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA) NCT05258448 | Odense University Hospital | — |
| Unknown | Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers NCT02119091 | Haiyan Li | Phase 1 |
| Completed | MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum NCT01719562 | Wake Forest University Health Sciences | N/A |
| Unknown | Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT) NCT01032278 | M.D. Anderson Cancer Center | N/A |
| Completed | Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D NCT01212926 | University Hospital, Bordeaux | N/A |
| Completed | Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab NCT01009918 | University of South Florida | Phase 2 |
| Unknown | Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer NCT01093235 | Cambridge University Hospitals NHS Foundation Trust | Phase 3 |
| Completed | Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab NCT00875238 | Vanderbilt University | — |
| Terminated | Aerobic Exercise in Patients Receiving Chemotherapy for Cancer NCT00728429 | Wake Forest University Health Sciences | N/A |
| Completed | CADY Study ICORG 08-01 NCT00968682 | Cancer Trials Ireland | — |
| Completed | Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorub NCT00577798 | University of Nebraska | — |
| Completed | Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With NCT00436566 | Mayo Clinic | Phase 2 |
| Terminated | Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomot NCT00563407 | AHS Cancer Control Alberta | — |
| Completed | Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or NCT00039481 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treati NCT00016276 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer NCT00003070 | Children's Oncology Group | Phase 3 |
| Terminated | Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma NCT00019864 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma NCT00003937 | Children's Oncology Group | Phase 3 |
| Completed | Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease NCT00005578 | Children's Oncology Group | Phase 3 |
| Completed | SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial NCT00002900 | SWOG Cancer Research Network | — |
| Completed | Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease NCT00002827 | Children's Oncology Group | Phase 3 |
| Completed | Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non- NCT01230983 | Children's Oncology Group | Phase 3 |